Characterization of acute adverse-effect profiles of selected antiepileptic drugs in the grip-strength test in mice

Pharmacological Reports

Volumn 61, Issue 4, 2009, Pages 737-742

  Zadrozniak, Anna ^a   Wojda, Ewa ^a   Wlaź, Aleksandra ^a   Łuszczki, Jarogniew J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Acute adverse effect profile; Antiepileptic drugs; Dose response relationship analysis; Grip strength; Linear regression; Protective index; Strength reducing dose by 50

Indexed keywords

ANTICONVULSIVE AGENT; CLONAZEPAM; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL ANIMAL; GRIP STRENGTH; LINEAR REGRESSION ANALYSIS; MALE; MOUSE; MUSCLE STRENGTH; NEUROTOXICITY; NONHUMAN;

EID: 70549098260     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70128-8     Document Type: Article

References (17)

1. Brodie MJ, Schachter SC: Fast Facts. Epilepsy, 2nd edn., Health Press, Oxford, 2001.
2. Deckers CL, Czuczwar SJ, Hekster YA, Keyser A, Kubova H, Meinardi H, Patsalos PN et al.: Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia, 2000, 41, 1364-1374. (Pubitemid 30813208)
3. Kwan P, Brodie MJ: Combination therapy in epilepsy: when and what to use. Drugs, 2006, 66, 1817-1829. (Pubitemid 44584005)
4. Kwan P, Brodie MJ: Refractory epilepsy: a progressive, intractable but preventable condition? Seizure, 2002, 11, 77-84.
5. Löscher W, Nolting B: The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV Protective indices. Epilepsy Res, 1991, 9, 1-10.
6. Łuszczki JJ, Andres MM, Czuczwar P, Cioczek-Czuczwar A, Wójcik-Ćwikła J, Ratnaraj N, Patsalos PN, Czuczwar SJ: Levetiracetam selectively potentiates the acute neurotoxic effects of topiramate and carbamazepine in the rotarod test in mice. Eur Neuropsychopharmacol, 2005, 15, 609-616.
7. Łuszczki JJ, Borowicz KK, Świa̧der M, Czuczwar SJ: Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis. Epilepsia, 2003, 44, 489-499.
8. Łuszczki JJ, Czuczwar M, Kiś J, Krysa J, Pasztelan I, Świa̧der M, Czuczwar SJ: Interactions of lamotrigine with topiramate and first-generation antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis. Epilepsia, 2003, 44, 1003-1013.
9. Łuszczki JJ, Czuczwar SJ: Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy. Prog Neuropsychopharmacol Biol Psychiatry, 2007, 31, 529-538.
10. Łuszczki JJ, Szadkowski M, Czuczwar SJ: Effect of NG-nitro-L-arginine on the anticonvulsant action of four second-generation antiepileptic drugs in pentetrazole-induced clonic seizures in mice. Pharmacol Rep, 2007, 59, 467-473.
11. Łuszczki JJ, Trojnar MK, Trojnar MP, Kimber-Trojnar Z, Szostakiewicz B, Zadrożniak A, Borowicz KK, Czuczwar SJ: Effects of three calcium channel antagonists (amlodipine, diltiazem and verapamil) on the protective action of lamotrigine in the mouse maximal electroshock-induced seizure model. Pharmacol Rep, 2007, 59,672-682.
12. Łuszczki JJ, Zadrożniak A, Wlaź A, Andres-Mach M, Dudra-Jastrzȩbska M, Zwoliński J, Misiuta-Krzesińska M, Sielski M: Characterization of acute adverse-effect profile of carbamazepine and valproate in the grip-strength test in mice. J Pre-Clin Clin Res, 2008, 2, 46-48.
13. Motulsky HJ, Christopoulos A: Fitting models to biological data using linear and nonlinear regression. A practical guide to curve fitting. GraphPad Software Inc., San Diego CA, 2003.
14. Perucca E, Kwan P: Overtreatment in epilepsy: how it occurs and how it can be avoided. CNS Drugs, 2005, 19, 897-908. (Pubitemid 41571990)
15. Perucca E: Pharmacological principles as a basis for polytherapy. Acta Neurol Scand Suppl, 1995, 162, 31-34.
16. Schmidt D: Strategies to prevent overtreatment with antiepileptic drugs in patients with epilepsy. Epilepsy Res, 2002, 52, 61-69. (Pubitemid 35351533)
17. Talarek S, Listos J, Fidecka S: Role of nitric oxide in the development of tolerance to diazepam-induced motor impairment in mice. Pharmacol Rep, 2008, 60, 475-482.